Mesalamine Controlled-Release Capsules and Trastuzumab-dkst Intravenous
Determining the interaction of Mesalamine Controlled-Release Capsules and Trastuzumab-dkst Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mesalamine
Brand name: Apriso, Asacol HD, Delzicol, Lialda, Pentasa, Canasa, Canasa Pac, Rowasa, SfRowasa
Synonyms: Mesalamine
Generic Name: trastuzumab
Brand name: Herceptin, Kanjinti, Ogivri
Synonyms: Trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mesalamine Controlled-Release Capsules-Trasylol
- Mesalamine Controlled-Release Capsules-Travasol
- Mesalamine Controlled-Release Capsules-Travatan
- Mesalamine Controlled-Release Capsules-Travatan Z
- Mesalamine Controlled-Release Capsules-Travatan Z Ophthalmic Solution
- Mesalamine Controlled-Release Capsules-Travel Sickness
- Trastuzumab-dkst Intravenous-Mesalamine Delayed Release Tablets
- Trastuzumab-dkst Intravenous-Mesalamine Long-Acting Capsules (Apriso)
- Trastuzumab-dkst Intravenous-Mesalamine Long-Acting Capsules (Delzicol)
- Trastuzumab-dkst Intravenous-Mesalamine Long-Acting Capsules (Pentasa)
- Trastuzumab-dkst Intravenous-Mesalamine rectal
- Trastuzumab-dkst Intravenous-Mesalamine Rectal Enema